Endometrial Mixed Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Mixed Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer [Phase 1]
A Phase 1 clinical trial is evaluating ONC201 in combination with atezolizumab for obesity-driven endometrial cancer, currently recruiting a…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer [NA]
Update on a clinical trial evaluating PET/CT and lymph node mapping to detect lymph node metastasis in high-risk endometrial cancer patients…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial of brivanib alaninate in patients with recurrent or persistent endometrial cancer has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial evaluating dalantercept for recurrent or persistent endometrial cancer has completed and posted results.